Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trialYuankai Shi, Peng Liu, Yan Xiong et al.|The Lancet Haematology|2019Cited by 248
Genomic and Transcriptomic Characterization of Natural Killer T Cell LymphomaJie Xiong, Weili Zhao, Bowen Cui et al.|Cancer Cell|2020Cited by 234
Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemiaBing Chen, Sai‐Juan Chen, Lu Jiang et al.|Proceedings of the National Academy of Sciences|2017Cited by 148
A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphomaYuankai Shi, Xin Zhang, Yongping Song et al.|Journal of Hematology & Oncology|2020Cited by 50
Immune tolerance induced by platelet‐targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediatedY. Chen, Qizhen Shi, Xiang Luo et al.|Journal of Thrombosis and Haemostasis|2017Cited by 34